US2022145280A1PendingUtilityA1

Novel recombinant factor c and method for producing the same, and method for measuring endotoxin

Assignee: SEIKAGAKU KOGYO CO LTDPriority: Dec 10, 2012Filed: Dec 17, 2021Published: May 12, 2022
Est. expiryDec 10, 2032(~6.4 yrs left)· nominal 20-yr term from priority
G01N 2333/96411G01N 33/56911C12N 9/6408G01N 33/579C12Y 304/21069C12Y 304/21084
78
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A horseshoe crab Factor C protein having activity of Factor C, wherein the horseshoe crab is selected from Tachypleus tridentatus, Limulus polyphemus, and Carcinoscorpius rotundicauda, and wherein the horseshoe crab Factor C protein is produced through being recombinantly expressed from a Chinese Hamster Ovary (CHO) DG44 cell or HEK cell.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A horseshoe crab Factor C protein having activity of Factor C,
 wherein the horseshoe crab is selected from the group consisting of  Tachypleus tridentatus,  and  Limulus polyphemus,      wherein the Factor C protein is produced through being recombinantly expressed from a Chinese Hamster Ovary cell, secreted into a culture supernatant and recovered from the culture supernatant, and   wherein the Factor C protein contains (α-2,3)-linked terminal sialic acid in a greater amount, as compared with a corresponding Factor C protein recombinantly expressed using Sf9 as a host cell.   
     
     
         2 . The horseshoe crab Factor C protein according to  claim 1 , which has a molecular weight of 115 kDa to 130 kDa, as measured through SDS-PAGE under a non-reducing condition. 
     
     
         3 . An endotoxin assay kit comprising the Factor C protein according to  claim 1  and one or more elements. 
     
     
         4 . A method for measuring endotoxin in a test specimen using an endotoxin assay agent comprising the Factor C protein according to  claim 1 .

Join the waitlist — get patent alerts

Track US2022145280A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.